Benzinga | Nov 9, 2021 05:51PM EST

Avidity Biosciences Q3 EPS $(0.68) Down From $(0.31) YoY, Sales $2.16M Up From $1.75M YoY

Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(0.68) per share. This is a 119.35 percent decrease over losses of $(0.31) per share from the same period last year. The company reported $2.16 million in sales this quarter. This is a 23.88 percent increase over sales of $1.75 million the same period last year.